Post by
GiveMeMoney on Feb 06, 2021 2:56am
a dead end.
CRDL's main medical will be knocked off within 1.5-2 years with a generic and it's cortical is a commodity that many will enter, with all the capacity on the continent, as well. it has no moat.
it's market is tiny. with respect to 'returns', if you would have invested whatever during the same amount of time that you've waited for 'THE POP' where would you have been with the winds in the past months in the market, with an awful lot less stress.
and you're still looking at a dead-end investment over the l/term.